Page last updated: 2024-08-22

tungsten and Thrombopenia

tungsten has been researched along with Thrombopenia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barre-Sinoussi, F; Chermann, JC; Vittecoq, D; Woerle, R	1
Burgard, M; Descamps, P; Guetard, D; Herson, S; Rouzioux, C; Rozenbaum, W; Sansonetti, P; Vittecoq, D	1

Trials

1 trial(s) available for tungsten and Thrombopenia

Article	Year
Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS. AIDS (London, England), 1989, Volume: 3, Issue:10 Topics: Antimony; Antiviral Agents; Drug Evaluation; Follow-Up Studies; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Platelet Count; Random Allocation; Reverse Transcriptase Inhibitors; Thrombocytopenia; Tungsten; Tungsten Compounds; Viral Core Proteins	1989

Article

Year

Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.

AIDS (London, England), 1989, Volume: 3, Issue:10

Topics: Antimony; Antiviral Agents; Drug Evaluation; Follow-Up Studies; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Platelet Count; Random Allocation; Reverse Transcriptase Inhibitors; Thrombocytopenia; Tungsten; Tungsten Compounds; Viral Core Proteins

1989

Other Studies

1 other study(ies) available for tungsten and Thrombopenia

Article	Year
Reverse transcriptase activity (RTA) in lymphocyte cultures of HIV-infected patients receiving short treatments of HPA 23. A biological evaluation. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1988, Volume: 42, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Cells, Cultured; Half-Life; Humans; Lymphocytes; RNA-Directed DNA Polymerase; Thrombocytopenia; Time Factors; Tungsten; Tungsten Compounds	1988

Article

Year

Reverse transcriptase activity (RTA) in lymphocyte cultures of HIV-infected patients receiving short treatments of HPA 23. A biological evaluation.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1988, Volume: 42, Issue:1

Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Cells, Cultured; Half-Life; Humans; Lymphocytes; RNA-Directed DNA Polymerase; Thrombocytopenia; Time Factors; Tungsten; Tungsten Compounds

1988